Harvard Apparatus Regenerative Technology, Inc.
HRGN- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001563665
In the last 90 days, Harvard Apparatus Regenerative Technology, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Harvard Apparatus Regenerative Technology, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1
- 0 vs. Q4 2021
- Shares held
- 15.4K
- −3.00K (−16.3%) vs. Q4 2021
- Total value
- $76.0K
- +$34.0K (+81.0%) vs. Q4 2021
- New holders
- 0
- 0 more added
- Sold out
- 0
- 1 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 1 | $58.0K |
| Q1 2022 | 1 | $76.0K |
| Q4 2021 | 1 | $42.0K |
| Q3 2021 | 1 | $55.0K |
| Q2 2021 | 1 | $31.0K |
| Q1 2021 | 1 | $34.0K |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Harvard Apparatus Regenerative Technology, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Grace & White Inc | 15,433 | $76.0K | 0.01% | −3,000−16.3% | Reduced |